MedTrace Logo

AI-Assisted Skin Assessment for Pressure Injury Prevention in Critical Care Nurses

NCT07318571 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-01-06

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether an artificial intelligence (AI)-assisted skin assessment tool can improve the accuracy of pressure-injury staging in critical-care nurses. The study also aims to understand whether the AI tool increases nurses' knowledge and confidence in performing skin assessments. The main questions it aims to answer are:

Does AI-assisted assessment improve the accuracy of pressure-injury staging compared with standard visual assessment?

Does the use of AI improve nurses' knowledge and confidence related to skin assessment and pressure-injury staging?

Researchers will compare nurses who use an AI-assisted mobile application with nurses who perform standard manual assessments to see whether the AI tool improves staging accuracy and supports early identification of pressure injuries.

Participants will:

Complete brief questionnaires about their knowledge and confidence before and after training

Perform skin assessments on their assigned ICU patients using either standard methods or the AI tool.

Have their assessments compared with those of a blinded wound-care specialist, who will determine the most accurate staging

Conditions

  • The Study Focuses on Skin Assessment and PI Staging in ICU Patients

Interventions

OTHER

ChatGPT Skin Assessment

ChatGPT Skin Assessment

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-24
Primary Completion
2026-02-28
Completion
2026-05-16

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07318571 on ClinicalTrials.gov